• slide-1
  • slide-1
  • slide-3
  • slide-4
  • slide-5

Cause and effect: aetiology and medicine working together to improve health
The 7th Asian Oncology Summit  will be held April 10-12, 2015 in Shanghai, China  alongside the 11th Annual Conference of the Organisation for Oncology and Translational Research. For the first time, the Viral Hepatitis Summit will also be run in parallel, providing a unique opportunity for specialists to come together across disciplines in several joint sessions.

Topics – Asian Oncology Summit / OOTR Conference
Main topics include: prevention, palliative care, gastrointestinal cancer, breast cancer, genitourinary cancer, lung cancer, translational oncology, haematological oncology, supportive oncology, melanoma, sarcoma, head and neck cancer, health economics, radiation oncology, gynaecological cancer, pharmacoeconomics, health-care delivery, molecular pathology, and endocrine late effects of cancer treatment (in conjunction with The Lancet Diabetes & Endocrinology)

Topics – Viral Hepatitis 2015
Topics include: treatment and prevention of hepatitis B, hepatitis C, hepatitis E, and hepatitis A, and mechanisms of viral carcinogenesis.

Register Now View Speakers View Programme
Conference Committee
  • Rob Brierley,
    Chair, AOS 2015, Deputy Editor, The Lancet Oncology
  • Louis Chow,
    Chair, 11th Annual Conference of OOTR, Executive Director OOTR
  • Masakazu Toi,
    Chair, 11th Annual Conference of OOTR, Chairman, OOTR
  • John McConnell,
    Chair, Viral Hepatitis 2015, Editor, The Lancet Infectious Diseases

    Ching-Lung Lai,
    Co-Chair, Viral Hepatitis 2015, The University of Hong Kong, Hong Kong

    Michael Manns,
    Co-Chair, Viral Hepatitis 2015, Hannover Medical School, Germany
Supporting Publications

Organised by
  • Elsevier
  • OOTR
  • Lancet Oncology
  • Lancet Infectious Diseases
Silver Sponsor
  • Hospira
  • Merck
Supported by
  • ASGO
  • ASID
  • CAMS
  • CSCO
  • Hong Kong Cancer Therapy
  • HKS
  • KACO
  • KCSG
  • Singapore Society
Twitter Hashtag